Insights Into Immunic Inc (IMUX) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

Stocks Info

Immunic Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Immunic Inc is $103.49M. A total of 1.28 million shares were traded on the day, compared to an average of 1.83M shares.

In the most recent transaction, Nash Duane bought 20,000 shares of IMUX for 0.83 per share on Jun 13 ’25. After the transaction, the Executive Chairman now owns 36,032 company shares. In a previous transaction on Jun 05 ’25, Tardio Jason bought 12,512 shares at 0.79 per share. IMUX shares that President and COO owns now total 12,512.

Among the insiders who bought shares, Vitt Daniel acquired of 15,000 shares on Jun 04 ’25 at a per-share price of $0.77. This resulted in the CEO and Director holding 29,000 shares of IMUX after the transaction. In another insider transaction, Neermann Joerg bought 70,000 shares at $0.77 per share on Jun 04 ’25. Company shares held by the Director now total 170,000.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, IMUX has a high of $2.11 and a low of $0.56.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. IMUX’s latest balance sheet shows that the firm has $86.86M in Cash & Short Term Investments as of fiscal 2021. There were $992.00k in debt and $11.40M in liabilities at the time. Its Book Value Per Share was -$0.06, while its Total Shareholder’s Equity was $127.11M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMUX is Buy with a score of 5.00.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.